AI assistant
NOVAVAX INC — Director's Dealing 2021
Aug 20, 2021
31982_dirs_2021-08-20_71bff1e9-372b-4177-b760-f55fe9059699.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-06-25
Reporting Person: MCMANUS MICHAEL A JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-25 | Common Stock | M | 3450 | — | Acquired | 9401 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-25 | Restricted Stock Units | $ | M | 3450 | Disposed | Common Stock (3450) | Direct |
Footnotes
F1: This amendment to the original Form 4 filed on June 29, 2021 is being filed to correct the number of restricted stock units ("RSUs") vested on June 25, 2021.
F2: Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F3: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.